Phase II Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Urothelial Cancer
Phase of Trial: Phase II
Latest Information Update: 01 Nov 2017
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary) ; Paclitaxel (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- 26 Oct 2017 Status changed from recruiting to discontinued.
- 19 Oct 2015 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
- 01 Oct 2015 New trial record